The report provides a detailed analysis essential for establishing a lidocaine production plant. It encompasses all critical aspects necessary for lidocaine production, including the cost of lidocaine production, lidocaine plant cost, lidocaine production costs, and the overall lidocaine production plant cost.
Additionally, the study covers specific expenditures associated with setting up and operating a lidocaine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Lidocaine serves as a local anesthetic agent that is majorly utilized for topical anesthesia. It is also used as a component in local and topical anesthetic products such as ointments, gels, and injectable solutions to cause numbness or loss of sensation during medical and dental procedures. Moreover, it is also utilized in the treatment of sore mouth and throat to reduce gagging during X-ray impressions. Additionally, it is also used to alleviate pain caused by shingles (Postherpetic neuralgia). It also finds its application in veterinary medicine to provide systemic analgesia in certain surgical procedures.
The market for lidocaine is majorly driven by its applications as an anesthetic and antiarrhythmic agent used for inducing numbness and treating ventricular tachycardia, which significantly increases its demand in the medical and pharmaceutical industries. Moreover, it is also utilized for infiltration anesthesia in dental patients during dental procedures, further enhancing its demand in the pharmaceutical and dental industries. Additionally, its usage in veterinary medicine for local anesthesia during surgical procedures in animals, remarkably boosts its demand in the veterinary medicine industry.
Its utilization as a topical ointment to numb the skin before certain surgical procedures effectively promote its demand in the medical and healthcare industries. Furthermore, several factors influence industrial lidocaine procurement, such as the availability and cost of production of its raw materials, cost and pricing, compliance with medical regulations, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc.
Raw Material for Lidocaine Production
According to the Lidocaine production plant project report, the major raw materials for Lidocaine production include 2,6-dimethyl nitrobenzene- Chloroacetyl Chloride- Chloroamide.
Production Process of Lidocaine
The extensive Lidocaine production cost report consists of the following industrial production process:
- Production via Reduction of an Aromatic Nitro Compound: In this process, the compound is isolated in the form of its bisulfate salt. The process is initiated by the reduction of 2,6-dimethyl nitrobenzene in the presence of iron or zinc to form 2,6-dimethylaniline, followed by the synthesis of α-diethylamino-2,6-dimethylacetanile. Further, α-diethylamino-2,6-dimethylacetanile undergoes acylation of the aniline by the highly reactive chloroacetyl chloride and alkylation of dimethylamine by the chloroamide, followed by the synthesis of the bisulfate salt of lidocaine.
Lidocaine is a type of amino amide anesthetic. It is a tertiary amine that decreases the rate of contractions of the heart by inhibiting the sodium channel. The molecular formula of the compound is 234.3373 g/mol, and its molecular formula is C14H22N2O. In addition to the aromatic unit, the lidocaine molecule also constitutes an amide, enyl, and carbonyl groups. It appears as a yellowish-white crystalline powder that is completely soluble in water, ethanol, and chloroform. The melting point and the boiling point of the compound are approximately 66-69 °C and 180-182 °C, respectively. It is stored away from light and moisture to prevent degradation.
